Bright Minds Biosciences (DRUG) Competitors $32.71 -0.71 (-2.12%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$32.54 -0.17 (-0.52%) As of 04/25/2025 06:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DRUG vs. WVE, MLYS, ETNB, COLL, DYN, ELVN, RCUS, CMRX, CDMO, and SYREShould you be buying Bright Minds Biosciences stock or one of its competitors? The main competitors of Bright Minds Biosciences include Wave Life Sciences (WVE), Mineralys Therapeutics (MLYS), 89bio (ETNB), Collegium Pharmaceutical (COLL), Dyne Therapeutics (DYN), Enliven Therapeutics (ELVN), Arcus Biosciences (RCUS), Chimerix (CMRX), Avid Bioservices (CDMO), and Spyre Therapeutics (SYRE). These companies are all part of the "pharmaceutical products" industry. Bright Minds Biosciences vs. Wave Life Sciences Mineralys Therapeutics 89bio Collegium Pharmaceutical Dyne Therapeutics Enliven Therapeutics Arcus Biosciences Chimerix Avid Bioservices Spyre Therapeutics Bright Minds Biosciences (NASDAQ:DRUG) and Wave Life Sciences (NASDAQ:WVE) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, community ranking, media sentiment, dividends, valuation, analyst recommendations and profitability. Does the MarketBeat Community believe in DRUG or WVE? Wave Life Sciences received 361 more outperform votes than Bright Minds Biosciences when rated by MarketBeat users. However, 100.00% of users gave Bright Minds Biosciences an outperform vote while only 67.84% of users gave Wave Life Sciences an outperform vote. CompanyUnderperformOutperformBright Minds BiosciencesOutperform Votes6100.00% Underperform VotesNo VotesWave Life SciencesOutperform Votes36767.84% Underperform Votes17432.16% Which has higher earnings and valuation, DRUG or WVE? Bright Minds Biosciences has higher earnings, but lower revenue than Wave Life Sciences. Bright Minds Biosciences is trading at a lower price-to-earnings ratio than Wave Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBright Minds BiosciencesN/AN/A-$2.06M-$0.17-192.41Wave Life Sciences$108.30M9.54-$57.51M-$0.79-8.52 Is DRUG or WVE more profitable? Bright Minds Biosciences has a net margin of 0.00% compared to Wave Life Sciences' net margin of -66.50%. Bright Minds Biosciences' return on equity of -5.85% beat Wave Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Bright Minds BiosciencesN/A -5.85% -5.68% Wave Life Sciences -66.50%-280.57%-52.90% Does the media prefer DRUG or WVE? In the previous week, Wave Life Sciences had 9 more articles in the media than Bright Minds Biosciences. MarketBeat recorded 11 mentions for Wave Life Sciences and 2 mentions for Bright Minds Biosciences. Bright Minds Biosciences' average media sentiment score of 1.90 beat Wave Life Sciences' score of 1.23 indicating that Bright Minds Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bright Minds Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Wave Life Sciences 7 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate DRUG or WVE? Bright Minds Biosciences presently has a consensus target price of $84.33, suggesting a potential upside of 157.82%. Wave Life Sciences has a consensus target price of $22.18, suggesting a potential upside of 229.60%. Given Wave Life Sciences' higher possible upside, analysts plainly believe Wave Life Sciences is more favorable than Bright Minds Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bright Minds Biosciences 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20Wave Life Sciences 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more volatility and risk, DRUG or WVE? Bright Minds Biosciences has a beta of -5.5, suggesting that its share price is 650% less volatile than the S&P 500. Comparatively, Wave Life Sciences has a beta of -0.93, suggesting that its share price is 193% less volatile than the S&P 500. Do insiders and institutionals have more ownership in DRUG or WVE? 40.5% of Bright Minds Biosciences shares are owned by institutional investors. Comparatively, 89.7% of Wave Life Sciences shares are owned by institutional investors. 42.7% of Bright Minds Biosciences shares are owned by insiders. Comparatively, 29.1% of Wave Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryBright Minds Biosciences beats Wave Life Sciences on 9 of the 17 factors compared between the two stocks. Get Bright Minds Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DRUG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DRUG vs. The Competition Export to ExcelMetricBright Minds BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$230.41M$6.71B$5.46B$7.81BDividend YieldN/A3.16%5.43%4.26%P/E Ratio-192.407.2322.4318.46Price / SalesN/A239.68391.42101.46Price / CashN/A65.8538.1834.62Price / Book5.586.306.684.19Net Income-$2.06M$143.17M$3.22B$248.05M7 Day Performance-1.21%8.00%6.25%6.54%1 Month Performance-9.57%-4.01%-2.70%-1.97%1 Year Performance2,873.64%-2.24%16.86%4.72% Bright Minds Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DRUGBright Minds Biosciences3.4945 of 5 stars$32.71-2.1%$84.33+157.8%+2,873.6%$230.41MN/A-192.40N/APositive NewsWVEWave Life Sciences4.2959 of 5 stars$6.00+6.2%$22.18+269.7%+44.4%$920.92M$108.30M-5.41240Gap DownMLYSMineralys Therapeutics2.4255 of 5 stars$13.92+3.9%$33.00+137.1%+12.4%$873.97MN/A-3.8228Short Interest ↑Positive NewsGap UpETNB89bio3.0064 of 5 stars$5.92+7.1%$27.56+365.5%-16.0%$864.23MN/A-2.0340Analyst ForecastOptions VolumeNews CoveragePositive NewsCOLLCollegium Pharmaceutical3.9182 of 5 stars$26.73+1.6%$43.60+63.1%-26.4%$858.89M$631.45M11.52210Positive NewsDYNDyne Therapeutics3.2808 of 5 stars$7.47+6.1%$47.46+535.4%-55.3%$845.01MN/A-2.10100Upcoming EarningsShort Interest ↑News CoverageGap DownELVNEnliven Therapeutics2.0017 of 5 stars$17.19+4.1%$40.33+134.6%+6.0%$842.38MN/A-9.0550News CoverageGap UpRCUSArcus Biosciences2.0619 of 5 stars$7.67-6.2%$30.25+294.4%-46.6%$806.41M$258M-2.43500Analyst ForecastGap DownCMRXChimerix3.0149 of 5 stars$8.54+0.2%$8.53-0.1%N/A$801.09M$212,000.00-9.0990Upcoming EarningsAnalyst ForecastNews CoverageCDMOAvid Bioservices0.7616 of 5 stars$12.50+0.1%$12.25-2.0%+70.0%$799.18M$139.91M-5.23320High Trading VolumeSYRESpyre Therapeutics1.9164 of 5 stars$13.02+6.5%$49.57+280.7%-57.9%$784.55M$890,000.00-1.74100Positive News Related Companies and Tools Related Companies Wave Life Sciences Competitors Mineralys Therapeutics Competitors 89bio Competitors Collegium Pharmaceutical Competitors Dyne Therapeutics Competitors Enliven Therapeutics Competitors Arcus Biosciences Competitors Chimerix Competitors Avid Bioservices Competitors Spyre Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DRUG) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Minds Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DRUG Stock Free DRUG Stock Alerts